Bausch Health Companies | VRX

Stock Price
10.16
Daily Change
-0.03 -0.25%
Monthly
10.26%
Yearly
20.75%
Q3 Forecast
10.12


Peers Price Chg Day Year Date
Aurora Cannabis 6.68 -0.10 -1.47% -14.90% Sep/08
Amgen 279.42 -4.22 -1.49% -14.24% Sep/08
ANI Pharmaceuticals 94.92 -0.43 -0.45% 62.31% Sep/08
Biogen 141.40 0.73 0.52% -29.02% Sep/08
Bristol-Myers Squibb 46.50 -0.64 -1.36% -4.14% Sep/08
Corcept Therapeutics 69.41 0.05 0.07% 100.03% Sep/08
Danaher 197.85 -2.36 -1.18% -27.51% Sep/08
Gilead Sciences 115.61 0.56 0.49% 46.06% Sep/08
Eli Lilly 741.23 14.02 1.93% -18.39% Sep/08
Novo Nordisk A/S 346.95 -3.05 -0.87% -60.89% Sep/08
Prestige Brands 63.87 -1.18 -1.81% -14.08% Sep/08
Pacira 26.23 -0.23 -0.85% 98.22% Sep/08
Perrigo 22.65 -0.64 -2.75% -20.79% Sep/05
Drreddys Laboratories 14.20 -0.15 -1.01% -82.08% Sep/08
Supernus Pharmaceuticals 46.24 0.24 0.52% 36.64% Sep/08
Vertex Pharmaceuticals 393.81 -2.31 -0.58% -16.35% Sep/08
Bausch Health Companies 10.16 -0.03 -0.25% 20.75% Sep/08
Canopy Growth 1.88 -0.14 -6.93% -71.52% Sep/08
Zoetis 151.41 -1.91 -1.25% -21.08% Sep/08

Indexes Price Day Year Date
TSX 29019 -31.39 -0.11% 26.02% Sep/08
Canada TSX 60 Index 1717 -4.72 -0.27% 23.54% Sep/08

Bausch Health Companies Inc traded at 10.16 this Monday September 8th, decreasing 0.03 or 0.25 percent since the previous trading session. Looking back, over the last four weeks, Bausch Health Companies lost 10.26 percent. Over the last 12 months, its price rose by 20.75 percent. Looking ahead, we forecast Bausch Health Companies Inc to be priced at 10.12 by the end of this quarter and at 9.94 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.